The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Increase Is Anticipated For The Pharmaceutical Manufacturing Market Over The 2026–2030 Period?
The pharmaceutical manufacturing market size has experienced significant growth in recent years. It is anticipated to expand from $572.33 billion in 2025 to $630.77 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.2%. This historical development can be linked to several factors, including the expanding global demand for drugs, the rise in chronic disease prevalence, increased investments in manufacturing capacity, improvements in formulation technologies, and the reinforcement of regulatory quality standards.
The pharmaceutical manufacturing market size is anticipated to experience robust growth in the upcoming years. It is projected to expand to $923.47 billion by 2030, achieving a compound annual growth rate (CAGR) of 10.0%. This expansion during the forecast period is primarily driven by increasing investments in smart manufacturing facilities, a rising adoption of advanced biologics production, the expansion of personalized medicine manufacturing, a growing focus on cost-efficient production models, and the increasing integration of digital quality management systems. Significant trends expected during this time include the increasing adoption of continuous manufacturing technologies, a rising focus on biologics and biosimilars production, the expansion of advanced quality control systems, growing integration of automation and robotics, and an enhanced emphasis on regulatory compliance.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24375&type=smp
What Underlying Factors Are Accelerating The Growth Of The Pharmaceutical Manufacturing Market?
The rising occurrence of chronic illnesses is anticipated to fuel the expansion of the pharmaceutical manufacturing market moving ahead. These conditions are enduring health issues, usually advancing gradually and lasting a minimum of a year, frequently demanding continuous medical care or restricting daily life. The growing incidence of chronic diseases stems from longer lifespans, inactive lifestyles, and poor eating habits, thereby boosting the need for extended healthcare options and proactive health initiatives. Pharmaceutical manufacturing plays a crucial role in managing chronic diseases by guaranteeing a consistent provision of vital drugs, fostering advancements in drug creation, and addressing the increasing requirement for successful prolonged treatment approaches. As an illustration, data from September 2024 provided by the National Health Service, a UK-based government body, indicates that 11% of individuals aged 35 and above suffer from advanced chronic kidney disease, a condition whose frequency and severity escalate with age. Almost 48% of individuals aged 75 and older have a degree of the illness, with 36% experiencing more serious forms. Consequently, the expanding prevalence of chronic ailments is stimulating development within the pharmaceutical manufacturing market.
How Is The Pharmaceutical Manufacturing Market Segmented Across Key Categories?
The pharmaceutical manufacturing market covered in this report is segmented –
1) By Molecule Type: Biologics And Biosimilars, Conventional Drugs
2) By Formulation: Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations
3) By Route Of Administration: Oral, Topical, Parenteral, Inhalations, Other Route Of Administrations
4) By Therapy Area: Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases
5) By Sales Channel: Retail, Non-retail
Subsegments:
1) By Biologics And Biosimilars: Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell Therapies, Gene Therapies, Hormones, Blood And Plasma Products
2) By Conventional Drugs: Analgesics, Antipyretics, Antibiotics, Antivirals, Antifungals, Antihypertensives, Antidepressants, Antidiabetics
How Are Trends Impacting The Pharmaceutical Manufacturing Market?
Major companies operating in the pharmaceutical manufacturing market are intensifying efforts to create advanced solutions, including fully automated RLT manufacturing facilities. This initiative aims to improve production efficiency, guarantee high-quality standards, and address the growing requirement for targeted cancer therapies. An automated RLT manufacturing facility is a state-of-the-art production site that leverages advanced automation technologies to streamline and optimize the production of radioligand therapies, thereby ensuring consistent, efficient, and scalable manufacturing. For instance, in January 2024, Novartis AG, a Switzerland-based pharmaceutical corporation, secured US Food and Drug Administration (FDA) approval for Pluvicto production at a cutting-edge radioligand therapy (RLT) manufacturing facility in Indianapolis. This approval is set to significantly boost the production capacity for its radioligand therapy medicines, which include Pluvicto and Lutathera. This expansion aligns with Novartis’ wider strategy to meet the increasing global demand for targeted cancer therapies and enhance accessibility for patients worldwide.
Who Are The Dominant Players Shaping The Pharmaceutical Manufacturing Market Landscape?
Major companies operating in the pharmaceutical manufacturing market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Lonza Group AG, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories, Cipla Limited, Samsung Biologics, FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Lupin Limited, Jubilant Pharmova Limited.
Read the full pharmaceutical manufacturing market report here:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-manufacturing-global-market-report
Which Region Is Projected To Dominate The Pharmaceutical Manufacturing Market During The Forecast Period?
North America was the largest region in the pharmaceutical manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Pharmaceutical Manufacturing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24375&type=smp
Browse Through More Reports Similar to the Global Pharmaceutical Manufacturing Market 2026, By The Business Research Company
Biopharmaceutical Third Party Logistics Global Market Report
Pharmaceutical Supply Chain Management Global Market Report
Chemical Logistics Global Market Report
https://www.thebusinessresearchcompany.com/report/chemical-logistics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
